| 0.0115 -0.001 (-4.17%) | 11-11 14:43 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.05 | 1-year : | 0.09 |
| Resists | First : | 0.04 | Second : | 0.07 |
| Pivot price | 0.01  |
|||
| Supports | First : | 0 | Second : | 0 |
| MAs | MA(5) : | 0.01 |
MA(20) : | 0.01 |
| MA(100) : | 0.03 |
MA(250) : | 0.15 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 96.7 |
D(3) : | 87 |
| RSI | RSI(14): 48.1 |
|||
| 52-week | High : | 0.69 | Low : | 0 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ TTOO ] has closed below upper band by 45.1%. Bollinger Bands are 87.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.01 - 0.01 | 0.01 - 0.01 |
| Low: | 0.01 - 0.01 | 0.01 - 0.01 |
| Close: | 0.01 - 0.01 | 0.01 - 0.01 |
Wed, 04 Jun 2025
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
Thu, 20 Feb 2025
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com
Tue, 18 Feb 2025
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals
Fri, 14 Feb 2025
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
Tue, 11 Feb 2025
T2 Biosystems to be delisted from Nasdaq - Investing.com
Tue, 07 Jan 2025
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 28 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 8 (%) |
| Held by Institutions | 38 (%) |
| Shares Short | 846 (K) |
| Shares Short P.Month | 942 (K) |
| EPS | -0.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.63 |
| Profit Margin | 0 % |
| Operating Margin | -511.9 % |
| Return on Assets (ttm) | -84.9 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 34.9 % |
| Gross Profit (p.s.) | -0.68 |
| Sales Per Share | 0.27 |
| EBITDA (p.s.) | -1.48 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -37 (M) |
| Levered Free Cash Flow | -26 (M) |
| PE Ratio | -0.39 |
| PEG Ratio | 0 |
| Price to Book value | -0.02 |
| Price to Sales | 0.04 |
| Price to Cash Flow | -0.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|